ATE237139T1 - Verfahren zur identifizierung personen empfindlich für betahemolytischer streptococci- vermittelter neuropsychiatrischer krankheiten - Google Patents

Verfahren zur identifizierung personen empfindlich für betahemolytischer streptococci- vermittelter neuropsychiatrischer krankheiten

Info

Publication number
ATE237139T1
ATE237139T1 AT96918399T AT96918399T ATE237139T1 AT E237139 T1 ATE237139 T1 AT E237139T1 AT 96918399 T AT96918399 T AT 96918399T AT 96918399 T AT96918399 T AT 96918399T AT E237139 T1 ATE237139 T1 AT E237139T1
Authority
AT
Austria
Prior art keywords
neuropsychiatric diseases
identifying persons
mediated neuropsychiatric
betahemolytic
streptococci
Prior art date
Application number
AT96918399T
Other languages
English (en)
Inventor
Susan E Swedo
Henrietta L Leonard
Albert J Allen
John B Zabriskie
Original Assignee
Us Gov Health & Human Serv
Univ Rockefeller
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Gov Health & Human Serv, Univ Rockefeller filed Critical Us Gov Health & Human Serv
Application granted granted Critical
Publication of ATE237139T1 publication Critical patent/ATE237139T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • G01N33/56944Streptococcus
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966Animal cells
    • G01N33/56972White blood cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896Neurological disorders, e.g. Alzheimer's disease
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2474/00Immunochemical assays or immunoassays characterised by detection mode or means of detection
    • G01N2474/20Immunohistochemistry assay
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/30Psychoses; Psychiatry
    • G01N2800/301Anxiety or phobic disorders
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/811Test for named disease, body condition or organ function

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Neurology (AREA)
  • Zoology (AREA)
  • Neurosurgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Image Processing (AREA)
  • Image Analysis (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Financial Or Insurance-Related Operations Such As Payment And Settlement (AREA)
AT96918399T 1995-06-06 1996-06-06 Verfahren zur identifizierung personen empfindlich für betahemolytischer streptococci- vermittelter neuropsychiatrischer krankheiten ATE237139T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47303395A 1995-06-06 1995-06-06
PCT/US1996/009743 WO1996039631A1 (en) 1995-06-06 1996-06-06 METHOD OF IDENTIFYING PERSONS SUSCEPTIBLE TO GROUP A β-HEMOLYTIC STREPTOCOCCI-MEDIATED NEUROPSYCHIATRIC DISORDERS

Publications (1)

Publication Number Publication Date
ATE237139T1 true ATE237139T1 (de) 2003-04-15

Family

ID=23877917

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96918399T ATE237139T1 (de) 1995-06-06 1996-06-06 Verfahren zur identifizierung personen empfindlich für betahemolytischer streptococci- vermittelter neuropsychiatrischer krankheiten

Country Status (10)

Country Link
US (1) US5866347A (de)
EP (1) EP0846267B1 (de)
JP (1) JP2001507440A (de)
AT (1) ATE237139T1 (de)
AU (1) AU697755B2 (de)
CA (1) CA2222737A1 (de)
DE (1) DE69627352D1 (de)
IL (1) IL122426A (de)
NZ (1) NZ310301A (de)
WO (1) WO1996039631A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6884591B2 (en) * 2001-06-25 2005-04-26 The Cleveland Clinic Foundation Peripheral marker of blood brain barrier permeability
US7144708B2 (en) * 2001-06-25 2006-12-05 The Cleveland Clinic Foundation Markers of blood barrier disruption and methods of using same
US7508965B2 (en) * 2004-06-01 2009-03-24 Lumidigm, Inc. System and method for robust fingerprint acquisition

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4743538A (en) * 1985-04-17 1988-05-10 The Rockefeller University Test for rheumatic fever and monoclonal antibodies useful therefor

Also Published As

Publication number Publication date
WO1996039631A1 (en) 1996-12-12
IL122426A0 (en) 1998-06-15
CA2222737A1 (en) 1996-12-12
EP0846267A1 (de) 1998-06-10
AU697755B2 (en) 1998-10-15
MX9709776A (es) 1998-10-31
IL122426A (en) 2001-01-11
AU6107396A (en) 1996-12-24
EP0846267B1 (de) 2003-04-09
NZ310301A (en) 1998-12-23
US5866347A (en) 1999-02-02
JP2001507440A (ja) 2001-06-05
DE69627352D1 (de) 2003-05-15

Similar Documents

Publication Publication Date Title
DE69220871D1 (de) Vorrichtung und Verfahren zur Auftrennung und Analyse von Vollblut
DE69729473D1 (de) Pharmazeutisch-genetische verfahren zur verwendung bei der behandlung von krankheiten des nervensystems
DE69635174D1 (de) Nichtinvasive Vorrichtung zur Blutuntersuchung
DE3883701D1 (de) Verfahren und Vorrichtung für multiplexierte Vektorquantifizierung.
DE69009545D1 (de) Verfahren zur Sprachanalyse und -synthese.
DE69518834D1 (de) Verfahren und Vorrichtung zur Bestimmung der Erythrozytensedimentationsrate
EP0625774A3 (de) Verfahren und Vorrichtung zur Sprachdetektion.
DE3887644D1 (de) Vorrichtung und Verfahren zur Identifizierung von Gerüchen.
ATE244018T1 (de) Herstellungb und verwendung eines spezifischen gaba-aalpha5 rezeptorligands zur behandlung der erkrankung von alzheimer
ATE98773T1 (de) Verfahren zur optischen analyse.
DE69626683D1 (de) Verfahren zur feststellung von antipolymerantikörper und diagnosetestsatz zur feststellung von siliconabhängigen krankheiten
DE3767123D1 (de) Verfahren zur bestimmung des haematokrit aus vollblut sowie vorrichtung zur durchfuehrung des verfahrens.
DE58904662D1 (de) Verfahren und vorrichtung zur glanzmessung.
DE69510772D1 (de) Verfahren zur quantifizierung von lbp in körperflüssigkeiten
DE69333076D1 (de) Test und behandlung von demyelinierenden krankheiten wie multiple sklerosis
DE69614958D1 (de) Gerät und Verfahren zur Detektion von Fingerabdruckmerkmalen
DE69204157D1 (de) Verfahren zur bestimmung von anti-rns-antikörpern.
ATE237139T1 (de) Verfahren zur identifizierung personen empfindlich für betahemolytischer streptococci- vermittelter neuropsychiatrischer krankheiten
FR2741518B1 (fr) Appareil pour estimer les fonctions intellectuelles d'une personne
DE69018840D1 (de) Verfahren und Vorrichtung zur Bestimmung des mittleren arteriellen Blutdruckes.
FI910324A7 (fi) Menetelmät ja testipakkaukset ihmisen leukosyyttiantigeeni-DNA:n havaitsemiseksi
DE69021547D1 (de) Vorrichtung und Verfahren zum Feststellen der Echtheit der Handschrift einer Person.
DE69022192D1 (de) Verfahren und Vorrichtung zur Randdickeabmessung eines Brillenglases.
NO973823L (no) Påvisning av antistoffproduksjon
DE69431051D1 (de) Verfahren zur bestimmung der diabetesanfälligkeit bei asymptomatischen patienten

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties